A. La Casta - Medical Oncology Department, Hospital Universitario Donostia

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 8 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin

J. Capdevila, J. Hernando, A. Teule,C. Lopez, R. Garcia-Carbonero, M. Benavent, A. Custodio,A. Garcia-Alvarez, A. Cubillo, V. Alonso, A. Carmona-Bayonas, T. Alonso-Gordoa,

Nature Communications（2023）

引用1浏览0WOSNATURE引用

The Axinet Trial (Getne1107): Axitinib Plus Octreotide Lar Improves Pfs By Blinded Central Radiological Assessment Vs Placebo Plus Octreotide Lar In G1-2 Extrapancreatic Nets

R. Garcia-Carbonero, M. Benavent,P. Jimenez Fonseca,D. Castellano,T. Alonso-Gordoa, A. Teule, A. Custodio, S. Tafuto,A. La Casta,F. Spada,C. Lopez,T. Ibrahim,

ANNALS OF ONCOLOGY（2021）

引用8浏览0引用

Durvalumab Plus Tremelimumab In Patients With Grade 3 Neuroendocrine Neoplasms Of Gastroenteropancreatic Origin: Updated Results From The Multicenter Phase Ii Dune Trial (Getne 1601)

J. Capdevila,S. Landolfi, J. Hernando, A. Teule, R. Garcia-Carbonero, A. Custodio, A. Cubillo, T. Alonso-Gordoa,A. Carmona-Bayonas,G. Crespo,M. Blanco,A. Viudez,

ANNALS OF ONCOLOGY（2021）

引用2浏览0引用

Nomogram to Predict Progression-free Survival in Patients with Well-differentiated, Stage IV Gastroenteropancreatic Neuroendocrine Tumors Treated with Somatostatin Analogues: Data of TRASGU-GETNE Study

P. Jimenez-Fonseca, V Alonso,M. C. Riesco, A. Custodio,J. Molina-Cerrillo,M. Sanchez Canovas, M. Benavent,J. Hernando Cubero,A. La Casta,C. Lopez, M. Marazuela Azpiroz,A. Carmona-Bayonas

NEUROENDOCRINOLOGY（2019）

引用0浏览0引用

Liver Metastases (Lm) From Intrahepatic Cholangiocarcinoma (Icca): Outcomes From The European Network For The Study Of Cholangiocarcinoma (Ens-Cca) Registry And Implications On Current American Joint Committee On Cancer (Ajcc) Staging

A. Lamarca,A. Santos, K. Utpatel,A. La Casta, S. Stock, A. Forner,J. Adeva Alfonso, T. Folseraas,L. Fabris, R. Macias, M. Krawczyk, M. Krawczyk,

ANNALS OF ONCOLOGY（2019）

引用1浏览0引用

1315PDevelopment and internal validation of a predictive nomogram of progression-free survival in well-differentiated stage IV gastroenteropancreatic neuroendocrine tumours treated with somatostatin analogues: GETNE-TRASGU study

R. Garcia-Carbonero,Vicente Alonso,Jaume Capdevila,M. Sánchez Cánovas,T Alonso,M Benavent,Ana Custodio,G. Crespo Herrero, Cristina López, J Hernando,M.C. Riesco Martínez,P Escudero,

ANNALS OF ONCOLOGY（2018）

引用0浏览0WOS引用

Long-Term Outcomes and Prognostic Factors of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs): An Update of a Large National Registry (RGETNE)

P. Jimenez-Fonseca,A. Castano, J. J. Pi Barrio, V Alonso, A. Custodio, M. Marazuela, M. Llanos,J. A. Diaz,C. Lopez, T. Alonso,C. Blanco,A. La Casta,

NEUROENDOCRINOLOGYno. SUPnan (2017): 81-81

引用0浏览0引用

Biliary tract cancers: SEOM clinical guidelines

M. Benavides, A. Antón,J. Gallego,M. A. Gómez, A. Jiménez-Gordo,A. La Casta, B. Laquente, T. Macarulla, J. R. Rodríguez-Mowbray,J. Maurel

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexicono. 12 (2015): 982-987

引用52浏览0WOS引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn